Oak Ridge Investments’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q1
Sell
-50,091
Closed -$3.11M 177
2020
Q4
$3.11M Sell
50,091
-13,385
-21% -$831K 0.27% 110
2020
Q3
$3.78M Sell
63,476
-28,238
-31% -$1.68M 0.29% 105
2020
Q2
$6.4M Sell
91,714
-7,468
-8% -$521K 0.54% 73
2020
Q1
$4.5M Sell
99,182
-12,973
-12% -$588K 0.46% 83
2019
Q4
$7.3M Sell
112,155
-13,660
-11% -$889K 0.54% 74
2019
Q3
$7.81M Sell
125,815
-55,167
-30% -$3.43M 0.59% 72
2019
Q2
$12.9M Sell
180,982
-20,741
-10% -$1.48M 0.89% 42
2019
Q1
$15.8M Sell
201,723
-118,505
-37% -$9.29M 1.01% 29
2018
Q4
$27.1M Sell
320,228
-19,044
-6% -$1.61M 1.95% 6
2018
Q3
$58.1M Sell
339,272
-23,221
-6% -$3.98M 3.21% 1
2018
Q2
$46.8M Sell
362,493
-33,740
-9% -$4.36M 2.65% 2
2018
Q1
$40.8M Sell
396,233
-118,445
-23% -$12.2M 2.27% 5
2017
Q4
$44M Sell
514,678
-185,365
-26% -$15.8M 2.1% 4
2017
Q3
$59.5M Sell
700,043
-207,419
-23% -$17.6M 2.42% 1
2017
Q2
$68.7M Sell
907,462
-7,138
-0.8% -$541K 2.19% 3
2017
Q1
$60.4M Sell
914,600
-154,750
-14% -$10.2M 2.03% 9
2016
Q4
$67.8M Sell
1,069,350
-229,115
-18% -$14.5M 2.2% 7
2016
Q3
$82.7M Sell
1,298,465
-92,450
-7% -$5.89M 2.15% 12
2016
Q2
$103M Sell
1,390,915
-118,298
-8% -$8.8M 2.66% 6
2016
Q1
$101M Sell
1,509,213
-22,612
-1% -$1.51M 2.54% 5
2015
Q4
$104M Sell
1,531,825
-4,881
-0.3% -$330K 2.48% 4
2015
Q3
$82.1M Buy
1,536,706
+759,294
+98% +$40.6M 1.96% 14
2015
Q2
$48.9M Buy
777,412
+53,960
+7% +$3.4M 1.04% 38
2015
Q1
$34.8M Buy
+723,452
New +$34.8M 0.78% 48